Cargando…

Analysis of Lung Metastases in Patients with Primary Extremity Sarcoma

Purpose: To investigate the incidence, radiographic findings, and the time course for the appearence of lung metastases from primary extremity sarcoma. Patients and methods: Four-hundred patients with extremity sarcoma were evaluated retrospectively for lung metastases. Multiple clinical factors wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Songür, N., Dinç, M., Özdilekcan, C., Eke, S., Ok, U., Oz, M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395516/
https://www.ncbi.nlm.nih.gov/pubmed/18521370
http://dx.doi.org/10.1080/13577140310001607284
_version_ 1782155524594204672
author Songür, N.
Dinç, M.
Özdilekcan, C.
Eke, S.
Ok, U.
Oz, M.
author_facet Songür, N.
Dinç, M.
Özdilekcan, C.
Eke, S.
Ok, U.
Oz, M.
author_sort Songür, N.
collection PubMed
description Purpose: To investigate the incidence, radiographic findings, and the time course for the appearence of lung metastases from primary extremity sarcoma. Patients and methods: Four-hundred patients with extremity sarcoma were evaluated retrospectively for lung metastases. Multiple clinical factors were analyzed for possible influence on the metastases-free interval and subsequent metastases development. Radiographic findings of metastases were also reviewed. Results: Ninety of 400 patients (23%) developed lung metastases. Median time from presentation to detection of metastasis was 8.0 ± 1.1 months (95% CI: 6.02–9.98). More than 75% of patients developed metastases within 1 year after presentation of the primary sarcoma. As disease grade increased, the metastases-free intervals shortened significantly. Histologically, synoviosarcoma and osteogenic sarcoma were more often associated with the development of lung metastases. In this subgroup, 54 patients (60%), the presence of solitary (11) or multiple (43) nodular metastases was the only radiological finding. In 36 of 90 patients (40%), parenchymal mass, pleural effusion, hilar lymphadenopathy and pneumothorax were found. Conclusions: Twenty-three percent of patients in our study developed lung metastases. As the grade of the disease increased, metastases-free intervals are shortened. Although it has been reported that lung metastases in patients with extremity sarcomas may present as solitary or multiple nodules in earlier trials with radiographic screening methods, the current review of 400 patients found that a substantial number of patients may present radiological appearances other than nodular formations.
format Text
id pubmed-2395516
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-23955162008-06-02 Analysis of Lung Metastases in Patients with Primary Extremity Sarcoma Songür, N. Dinç, M. Özdilekcan, C. Eke, S. Ok, U. Oz, M. Sarcoma Research Article Purpose: To investigate the incidence, radiographic findings, and the time course for the appearence of lung metastases from primary extremity sarcoma. Patients and methods: Four-hundred patients with extremity sarcoma were evaluated retrospectively for lung metastases. Multiple clinical factors were analyzed for possible influence on the metastases-free interval and subsequent metastases development. Radiographic findings of metastases were also reviewed. Results: Ninety of 400 patients (23%) developed lung metastases. Median time from presentation to detection of metastasis was 8.0 ± 1.1 months (95% CI: 6.02–9.98). More than 75% of patients developed metastases within 1 year after presentation of the primary sarcoma. As disease grade increased, the metastases-free intervals shortened significantly. Histologically, synoviosarcoma and osteogenic sarcoma were more often associated with the development of lung metastases. In this subgroup, 54 patients (60%), the presence of solitary (11) or multiple (43) nodular metastases was the only radiological finding. In 36 of 90 patients (40%), parenchymal mass, pleural effusion, hilar lymphadenopathy and pneumothorax were found. Conclusions: Twenty-three percent of patients in our study developed lung metastases. As the grade of the disease increased, metastases-free intervals are shortened. Although it has been reported that lung metastases in patients with extremity sarcomas may present as solitary or multiple nodules in earlier trials with radiographic screening methods, the current review of 400 patients found that a substantial number of patients may present radiological appearances other than nodular formations. Hindawi Publishing Corporation 2003-06 /pmc/articles/PMC2395516/ /pubmed/18521370 http://dx.doi.org/10.1080/13577140310001607284 Text en Copyright © 2003 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Songür, N.
Dinç, M.
Özdilekcan, C.
Eke, S.
Ok, U.
Oz, M.
Analysis of Lung Metastases in Patients with Primary Extremity Sarcoma
title Analysis of Lung Metastases in Patients with Primary Extremity Sarcoma
title_full Analysis of Lung Metastases in Patients with Primary Extremity Sarcoma
title_fullStr Analysis of Lung Metastases in Patients with Primary Extremity Sarcoma
title_full_unstemmed Analysis of Lung Metastases in Patients with Primary Extremity Sarcoma
title_short Analysis of Lung Metastases in Patients with Primary Extremity Sarcoma
title_sort analysis of lung metastases in patients with primary extremity sarcoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395516/
https://www.ncbi.nlm.nih.gov/pubmed/18521370
http://dx.doi.org/10.1080/13577140310001607284
work_keys_str_mv AT songurn analysisoflungmetastasesinpatientswithprimaryextremitysarcoma
AT dincm analysisoflungmetastasesinpatientswithprimaryextremitysarcoma
AT ozdilekcanc analysisoflungmetastasesinpatientswithprimaryextremitysarcoma
AT ekes analysisoflungmetastasesinpatientswithprimaryextremitysarcoma
AT oku analysisoflungmetastasesinpatientswithprimaryextremitysarcoma
AT ozm analysisoflungmetastasesinpatientswithprimaryextremitysarcoma